The expanding demand for controlled immunological research and therapeutic development has spurred significant progress in recombinant growth factor manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique biological roles, are frequently manufactured using various expression methods, including bacterial hosts, mammalian cell cultures, and